TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NBP

NovaBridge Biosciences

Healthcare · Biotechnology

1.40$ -1.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

NovaBridge Biosciences (NBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 37 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NBP
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
1,025 2,376 1,738 6,334 879 4,074 369 1,552 37
692 2,037 1,361 5,344 750 3,626 330 1,290 31
308 1,588 1,137 4,759 553 3,214 292 498 30
574 1,844 1,169 4,790 671 3,449 312 1,266 30
4.1 9.4 55 358 61 4.8 1.8 8.6 0.3
– -216 -56 – 4.3 -80 29 – –
163 163 163 163 26 163 0.0 – –
149 149 149 120 19 119 17 – –
1,325 3,331 3,772 712 163 1,065 126 84 4.2
195 346 588 576 98 660 58 62 3.8
99 80 57 8.1 4.8 6.2 0.6 6.0 0.1
– – – – – – 8.3 – –
410 -955 1,069 5,627 715 3,008 243 1,468 33
-358 -1,014 -2,494 -2,023 -683 -6,767 -1,264 -9,387 -190
58 58 58 68 76 83 83 81 42

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?